| Subject: | FDA Issues Drug Recall for Ultravist Injection; FDA Issues Drug Warning for Bismacine/Chromacine |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 26 Jul 2006 - 12:00 am |
| Notice: FDA Issues Drug Recall for Ultravist Injection; FDA Issues Drug Warning for Bismacine/Chromacine
The FDA has issued multiple recalls and warnings in the past several days.
Recall of of Ultravist (iopromide) Injection 370mgl/mL, 125 ml
Bismacine/Chromacine Warning
Recall of of Ultravist (iopromide) Injection 370mgl/mL, 125 ml
Audience: Hospital Risk Managers, Imaging Center... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCES:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
